GlassScriptPhysician profile
William Patrick Guthrie
NPI 1922661271
$495.61
in general payments reported to CMS, 2019-2025
12 companies · $112 in 2025
The $112 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $98.74 · 2023: $172 · 2024: $114 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $144.03 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Seqirus USA INC | $74.85 | 2022-2025 | Flucelvax Quadrivalent, Flucelvax |
| Corium, LLC | $41.10 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $39.56 | 2023-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $38.86 | 2025 | Jornay Pm |
| Pfizer INC. | $36.53 | 2023-2024 | |
| Tris Pharma INC | $27.58 | 2024-2025 | Dyanavel Xr, Onyda Xr |
| Sanofi-Aventis U.S. LLC | $27.34 | 2024 | |
| Verrica Pharmaceuticals INC. | $19.65 | 2024 | Ycanth |
| Cranial Technologies, INC | $16.79 | 2022 | |
| Sobi, INC | $15.14 | 2023 | |
| Phadia US INC. | $14.18 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Guthrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.